This edge would as a result be extremely important for affected individual safety in vivo if conolidine were to get validated in people. Understanding conolidine’s safety profile remains a priority. Early preclinical studies suggest it doesn't induce critical respiratory despair like opioids or gastrointestinal risks affiliated with NSAIDs. On https://hansm444gec0.wikipresses.com/user